Clinical Trial Update: Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluate Triplezumab with CAPEOX as neoadjuvant therapy for locally advanced colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• CAPEOX regimen
• Triplezumab (Triplezumab)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Locally Advanced Colon Cancer | Phase 2 | Status: UNKNOWN